| 引用本文: | 魏裕涛,梁凯桐,何懿,刘子志.基于专利文献计量的广金钱草发明专利信息研究[J].中国现代应用药学,2020,37(2):230-236. |
| WEI Yutao,LIANG Kaitong,HE Yi,LIU Zizhi.Study of Patent Information of Inventions of Desmodium Based on Patent Analysis[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(2):230-236. |
|
| 本文已被：浏览 1425次 下载 767次 |
码上扫一扫！ |
|
|
| 基于专利文献计量的广金钱草发明专利信息研究 |
|
魏裕涛1,2, 梁凯桐3,2, 何懿1, 刘子志4,2
|
|
1.广州医科大学附属第二医院科研管理科, 广州 510260;2.广东省中医药健康服务与产业发展研究中心, 广州 510006;3.广东省技术经济研究发展中心, 广州 510030;4.广州中医药大学经济与管理学院, 广州 510006
|
|
| 摘要: |
| 目的 分析广金钱草发明专利的经济信息、法律信息及技术信息，为后续有关研发及发明专利申请活动提供参考。方法 检索、筛选1985—2018年的广金钱草中药发明专利，运用专利文献计量法对广金钱草发明专利进行信息挖掘。结果 国外申请人主要为日本医药企业，国内近6年才形成重点申请人，主要为武汉与广西医药企业；从人福医药企业的申请经历情况来看，广金钱草难以用专利形式进入日韩、北美市场；同时国内转化为中药新药的几率低，重点授权人发明专利不足以形成专利网等问题。结论 经过分析，本研究认为国内广金钱草申请人宜先立足于国内市场，且宜注重围绕“广金钱草提取物提取方法”合成同一中药材不同的提取物进行产品开发，最后不能忽视剂型、治疗适应证及药物配伍方面的覆盖面以及应用创新。 |
| 关键词: 广金钱草 发明专利 经济信息 法律信息 技术信息 |
| DOI：10.13748/j.cnki.issn1007-7693.2020.02.020 |
| 分类号:R282.7 |
| 基金项目:广州市哲学社会科学“十三五”规划2018年度课题（2018GZGJ66）；广东省中医药健康服务产业发展研究中心项目（2019ZDA01） |
|
| Study of Patent Information of Inventions of Desmodium Based on Patent Analysis |
|
WEI Yutao1,2, LIANG Kaitong3,2, HE Yi1, LIU Zizhi4,2
|
|
1.Scientific Research Management Department, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China;2.R & D Center of Health Services and Industries of Guangdong Provincial Chinese Medicine, Guangzhou 510006, China;3.R & D Center of Technologies and Economics of Guangdong Province, Guangzhou 510030, China;4.School of Economics and Management, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
|
| Abstract: |
| OBJECTIVE To analyze the economic, legal and technical information of the invention patents of Desmodii Styracifolii Herba, providing suggestions for the subsequent research and application of invention patent. METHODS Searching and screening the invention patents of Desmodii Styracifolii Herba from 1985 to 2018, as to use the method of patent bibliometrics to have a data mining on their information of invention patents. RESULTS The foreign applicants are mainly Japanese pharmaceutical enterprises, and the domestic key applicants have been formed in the past six years, mainly Wuhan and Guangxi pharmaceutical enterprises.According to the application experience of Humanwell healthcare enterprise, it is difficult for the invention patents of Desmodii Styracifolii Herba to enter the markets of Japan, South Korea and North America.At the same time, the probability of transforming into new Chinese medicine in China is low, and the invention patents of key owners are not enough to form a patent network. CONCLUSION Based on the analysis, it is suggested that the applicant should first base himself on the domestic market, and focus on the product development by synthesizing different extracts of the same Chinese herbal medicine,then the coverage and application innovation of dosage forms, treatment indications and drug compatibility should not be ignored. |
| Key words: Desmodii Styracifolii Herba inventional patent economic information legal information technical information |
